The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase II trial of olaparib in combination with ceralasertib in patients with recurrent osteosarcoma.
 
Suzanne J. Forrest
No Relationships to Disclose
 
Michael D. Kinnaman
No Relationships to Disclose
 
J Andrew Livingston
Research Funding - Repare Therapeutics (Inst)
Other Relationship - Guidepoint Global
 
Kieuhoa Tran Vo
No Relationships to Disclose
 
Priscilla Merriam
No Relationships to Disclose
 
Catherine Clinton
No Relationships to Disclose
 
Kylene Desmith
No Relationships to Disclose
 
Kerri Cavanaugh
No Relationships to Disclose
 
Brunella Felicetti
Employment - AstraZeneca
Stock and Other Ownership Interests - AstraZeneca
 
Simon Smith
Employment - AstraZeneca
Stock and Other Ownership Interests - AstraZeneca
 
Emma Dean
Employment - AstraZeneca/MedImmune
Stock and Other Ownership Interests - AstraZeneca (I); AstraZeneca/MedImmune
Travel, Accommodations, Expenses - AstraZeneca
 
Pei-Chi Kao
No Relationships to Disclose
 
Wendy B. London
Consulting or Advisory Role - ArQule; Jubilant Radiopharma
Research Funding - Agios; Aileron Therapeutics; Bluebird Bio; Bristol-Myers Squibb; Novartis
Travel, Accommodations, Expenses - ArQule
 
E. Alejandro Sweet-Cordero
No Relationships to Disclose
 
Katherine A. Janeway
Honoraria - Foundation Medicine
Consulting or Advisory Role - Bayer; Ipsen; Ipsen
Travel, Accommodations, Expenses - Bayer